J&J | JNJ - Zahlungsmittel Und Äquivalente

Aktienkurs
238.99
Täglich Wechseln
-2.14 -0.89%
Monatlich
-1.94%
Jährlich
60.73%
Q2 Prognose
235.72




Zahlungsmittel Und Äquivalente Veränderung Datum
AbbVie USD 5.23B 400M 2025-12
Abbott USD 8.52B 1.01B 2025-12
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Baxter International USD 1.97B 240M 2025-12
Bayer EUR 5.9B 1.34B 2025-09
Becton, Dickinson and Co. USD 740M 99M 2025-12
Biogen USD 3.01B 854.3M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
CONMED USD 38.93M 4.99M 2025-09
Cooper Companies USD 110.6M 14.3M 2025-09
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Globus Medical USD 526.16M 154.39M 2025-12
Hologic USD 2.17B 208.5M 2025-12
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
J&J USD 19.71B 1.48B 2025-12
Medtronic USD 1.15B 135M 2025-12
Merck USD 18.17B 10.16B 2025-09
Merit Medical Systems USD 446.4M 53.95M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12
Zoetis USD 2.08B 649M 2025-09